Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
15.09
+0.27 (1.79%)
At close: Jun 5, 2025, 4:00 PM
15.11
+0.02 (0.17%)
After-hours: Jun 5, 2025, 4:04 PM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $612.68 million as of June 5, 2025. Its market cap has decreased by -67.52% in one year.
Market Cap
612.68M
Enterprise Value
-89.65M
1-Year Change
-67.52%
Ranking
Category
Stock Price
$15.09
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $612.68M, an increase of 59.01%. That is a compound annual growth rate of 9.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 601.92M | -6.13% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.73B |
| Johnson & Johnson | 368.61B |
| AbbVie | 332.08B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.60B |
| Abbott Laboratories | 230.63B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |